Molnupiravir By Merck, Ivermectin And Profits by Dr. Jose Luis Abreu

First published at 20:08 UTC on October 5th, 2021.

Donate and support my work: https://earthnewspaper.com/donate

Merck owned Ivermectin patent from 1981 until it expired in 1996. Generic drugs have low profit margins, so the pharma mafia clones shadow drugs. The US patent office has rejected over 7…

MORE
CategoryNews & Politics
SensitivityNormal - Content that is suitable for ages 16 and over
DISCUSS THIS VIDEO